Comparison of Oral Semaglutide With Matched Oral Semaglutide Placebo as an Early Treatment for Latino Adults With Type 2 Diabetes Receiving Enhanced Lifestyle Care
Latest Information Update: 29 May 2023
At a glance
- Drugs Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 May 2023 Status changed from recruiting to discontinued.
- 07 Mar 2022 Planned End Date changed from 18 Jan 2024 to 29 Dec 2023.
- 07 Mar 2022 Planned primary completion date changed from 19 Nov 2023 to 29 Dec 2023.